Jeffery RW, Wing RR, Mayer RR Are smaller weight losses or more achievable weight loss goals better in the long term for obese patients? J Consult Clin Psychol. 1998 Aug;66(4):641-5.
Jeffery RW, Wing RR, Sherwood NE, Tate DF Physical activity and weight loss: does prescribing higher physical activity goals improve outcome? Am J Clin Nutr. 2003 Oct;78(4):684-9.
Jeffery RW, Wing RR, Thorson C, Burton LR Use of personal trainers and financial incentives to increase exercise in a behavioral weight-loss program. J Consult Clin Psychol. 1998 Oct;66(5):777-83.
Jeffery RW, Wing RR Long-term effects of interventions for weight loss using food provision and monetary incentives. J Consult Clin Psychol. 1995 Oct;63(5):793-6.
Raynor HA, Jeffery RW, Tate DF, Wing RR Relationship between changes in food group variety, dietary intake, and weight during obesity treatment. Int J Obes Relat Metab Disord. 2004 Jun;28(6):813-20.
Raynor HA, Polley BA, Wing RR, Jeffery RW Is dietary fat intake related to liking or household availability of high- and low-fat foods? Obes Res. 2004 May;12(5):816-23.
Wing RR, Gorin AA Behavioral techniques for treating the obese patient. Prim Care. 2003 Jun;30(2):375-91. Review.
Wing RR, Hill JO Successful weight loss maintenance. Annu Rev Nutr. 2001;21:323-41. Review.
Wing RR, Jeffery RW, Hellerstedt WL A prospective study of effects of weight cycling on cardiovascular risk factors. Arch Intern Med. 1995 Jul 10;155(13):1416-22.
Wing RR, Jeffery RW, Pronk N, Hellerstedt WL Effects of a personal trainer and financial incentives on exercise adherence in overweight women in a behavioral weight loss program. Obes Res. 1996 Sep;4(5):457-62.
Wing RR, Jeffery RW Benefits of recruiting participants with friends and increasing social support for weight loss and maintenance. J Consult Clin Psychol. 1999 Feb;67(1):132-8.
Wing RR, Jeffery RW Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance? Int J Obes Relat Metab Disord. 1995 Jan;19(1):67-73.
Wing RR, Jeffery RW Food provision as a strategy to promote weight loss. Obes Res. 2001 Nov;9 Suppl 4:271S-275S. Review.
Wing RR, Jeffery RW Prescribed "breaks" as a means to disrupt weight control efforts. Obes Res. 2003 Feb;11(2):287-91.
Wing RR Behavioral interventions for obesity: recognizing our progress and future challenges. Obes Res. 2003 Oct;11 Suppl:3S-6S.
Wing RR Behavioral treatment of severe obesity. Am J Clin Nutr. 1992 Feb;55(2 Suppl):545S-551S. Review.
Wing RR Changing diet and exercise behaviors in individuals at risk for weight gain. Obes Res. 1995 Sep;3 Suppl 2:277s-282s. Review.
Wing RR Insulin sensitivity as a predictor of weight regain. Obes Res. 1997 Jan;5(1):24-9.
Wing RR Obesity and weight gain during adulthood: a health problem for United States women. Womens Health Issues. 1992 Summer;2(2):114-20; discussion 120-2.
Wing RR Physical activity in the treatment of the adulthood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc. 1999 Nov;31(11 Suppl):S547-52.
Wirfält AK, Jeffery RW Using cluster analysis to examine dietary patterns: nutrient intakes, gender, and weight status differ across food pattern clusters. J Am Diet Assoc. 1997 Mar;97(3):272-9.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
